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This study was conducted to investigate the possible protective effect of ellagic acid (EA) on cyclosporine A
(CsA)-induced testicular and spermatozoal damages associated with oxidative stress in male rats. Forty adult
male Sprague–Dawley rats were divided into 4 groups of 10 animals each. Control group was used as
placebo. Cyclosporine group received CsA at the dose of 15 mg/kg/day. Ellagic acid group was treated with
EA (10 mg/kg/day). Cyclosporine plus ellagic acid group received CsA+EA. Reproductive organs were
weighed and epididymal sperm characteristics and histopathological structure of testes were examined
along with malondialdehyde (MDA) and glutathione (GSH) levels, glutathione-peroxidase (GSH-Px) and
catalase (CAT) activities in testicular tissue. CsA significantly decreased the weights of testes and ventral
prostate, epididymal sperm concentration, motility, testicular tissue glutathione (GSH), glutathione-
peroxidase (GSH-Px) and catalase (CAT), diameters of seminiferous tubules and germinal cell layer
thickness, and it significantly increased malondialdehyde (MDA) level and abnormal sperm rates along with
degeneration, necrosis, immature germ cells, congestion and atrophy in testicular tissue. However, the CsA
plus EA treatment attenuated all the CsA-induced negative changes observed in the testicular tissue, sperm
and oxidant/antioxidant parameters. In conclusion, CsA-induced oxidative stress leads to the structural and
functional damages in the testicular tissue and sperm quality of rats, and also EA has a protective effect on
these damages.
© 2009 Elsevier B.V. All rights reserved.
1. Introduction
Mythic literatures richly describe the transplantation as a cure for
diseases although theclinical practice of transplantation relatively spans
a few decades. Today, organ and bone marrow transplants are success-
fully performed. But, the rejection reactions occur when a foreign organ
is attacked by the body's immune system. Many immunosuppressive
drugs are used to prevent the rejection reactions. Although the modern
era of pharmacologic immunosuppression has initiated with the
introduction of the antiproliferative drug, 6-mercaptopurine, the
major advance in immunosuppression in the past three decades has
been the development of pharmacologic agents, the prototype of which
is cyclosporine A [1].
CsA, a neutral lipophilic cyclic undecapeptide (C6H11N1lO12) was
isolated from the fungus Tolypocladium inflatum gams. Although it was
firstly identified in 1976 as a novel antibiotic agent, it was subsequently
discovered to be a powerful immunosuppressive agent [2]. Nowadays,
CsA is successfully used in transplant medicine and in the therapy of
autoimmune diseases such as uveitis [3], rheumatic arthritis [4] and
psoriasis [5]. The potent immunosuppressant effect of CsA is attributed
to its specific inhibiting feature on the lymphokine generation,
differentiation and signal transduction pathways of T cell receptor
[6,7]. However, it has been reported that CsA causes renal [8,9], hepatic
and cardiac damages [9] and gingival hypertrophy, tremor, increased
blood pressure [6] as well as testicular [10–12] and spermatozoal
toxicity [12–16] in experimental animals.
Spermatozoa are germ cells that have a pivotal role at fertilisation.
Infertility is a problem with a large magnitude. Sperm damages are
one of the factors that cause infertility. Reactive oxygen species (ROS)
like hydrogen peroxide (H2O2), superoxide anion (O2−U) or molecules
and/or hydroxyl radical (UOH) affect both male and female gametes
[17]. ROS produced by spermatozoa play an important role in normal
physiologic processes such as sperm capacitation, acrosome reaction,
oocyte fusion, and stabilization of the mitochondrial capsule in the
mid-piece [18–20]. However, uncontrolled production of ROS that
exceeds the antioxidant capacity of the seminal plasma leads to
oxidative stress, which is harmful to spermatozoa through a variety of
mechanisms [20–22]. It has been documented that the biochemical
mechanism of CsA-induced toxicity in many organs including kidney
[8,9], liver, heart [9] and ovary [23] is attributed to the oxidative
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stress. CsA-induced direct damages in hypo-gonadic axis [13–15] and
Sertoli cell phagocytic function [11] have been considered for
testicular and spermatozoal toxicity up to our earlier study was
published in 2007 [12]. In our study we additionally demonstrated
that CsA causes both testicular and spermatozoal toxicity by affecting
the oxidant/antioxidant balance of testis [12].
It has been reported that exogenous antioxidants such as lycopene
[8], N-acetylcysteine [24], black grape extract [23] and taurine [25]
could have a therapeutic role against CsA-induced different organ
toxicity in non-transplanted experimental animals. Recently, there is
growing interest in understanding the role and mechanism of the
phytochemicals: polyphenolics, flavonoids and phenyl propanoids as
inhibitors of oxidative stress [26]. Among all phytochemicals, ellagic
acid (EA; 2,3,7,8-tetrahydroxy[1]-benzopyrano[5,4,3-cde][1]benzo-
pyran-5,10-dione) has been receiving the most attention because of
its wide array of biological properties, such as radical scavenging,
chemopreventive [27–29], antiatherogenic, antiapoptotic [30] and
estrogen receptor modulator [31] properties. Raspberries, strawber-
ries, walnuts, longan seed, mango kernel [32,33] and pomegranate
[34] are rich plants with respect to EA. EA contains four hydroxyl
groups and two lactone groups in which hydroxyl group is known to
increase antioxidant activity in lipid peroxidation and protect cells
from oxidative damage [35]. Our recent report [29] has demonstrated
that exogenous EA administration to rats protects testicular tissue and
spermatozoa from cisplatin, a chemotherapeutic agent-induced
toxicity by decreasing lipid peroxidation and increasing enzymatic
antioxidant activities. In the light of above information, the present
study was designed to investigate whether EA has possible protective
effect against CsA-induced negative changes in epididymal sperm
characteristics and testicular tissue associated with oxidative stress in
rats.
2. Materials and methods
2.1. Chemicals
CsA (Sandimmun® enj. sol., 50 mg/ml) was purchased from
Novartis (Istanbul, Turkey). EA was supplied from Fluka (Steinheim,
Germany) and the other chemicals were purchased from Sigma-
Aldrich Chemical Co. (St. Louis, MO, USA).
2.2. Animals, experimental design and sample collection
Forty healthy adult male Sprague–Dawley rats (8 weeks old, 200–
240 g body weight) were used in this study. The animals were
obtained from Fırat University, Experimental Research Centre (Elazığ,
Turkey) and were housed under standard laboratory conditions
(temperature 24±3°C, humidity 40–60%, a 12-h light:12-h dark
cycle). A commercial pellet diet (Elazığ Food Company, Elazığ, Turkey)
and fresh drinking water were given ad libitum. The protocol for the
animal use was approved by the Institutional Review Board of the
National Institute of Health and Local Committee on Animal Research.
CsA was subcutaneously injected to the animals at the dose of
15 mg/kg. EA is hardly dissolved under natural condition. Therefore, it
was dissolved in alkaline solution (0.01 NNaOH; approximately pH12).
pH of the final solution after the addition of EA was approximately 8.
This final solution (pH≈8) was administered to the animals by gavage
at the dose of 10 mg/kg. All treatments were maintained daily for
21 days. The dose and administration period of CsA and EA were
selected, according to previous studies [9,12,29]. The animals were
randomly divided into four experimental groups of 10 rats in each.
These groups were arranged as follows: the control group was used
as placebo and, was given subcutaneous injection of 0.5 ml isotonic
saline+0.5 ml slightly alkaline solution. The cyclosporine group
received subcutaneous injection of CsA+0.5 ml slightly alkaline
solution. The ellagic acid group was administered subcutaneous
injection of 0.5 ml isotonic saline+EA. The cyclosporine plus ellagic
acid group received subcutaneous injection of CsA+EA.
The rats were killed under slight ether anaesthesia at the end of a
21 day treatment period. Testes, epididymides, seminal vesicles and
ventral prostate were removed, cleared of adhering connective tissue
and weighed. One of the testes was fixed in 10% formalin solution for
histopathological examinations. The other testes samples were also
stored at−20 °Cuntil biochemical analyses. For the enzymatic analyses,
testicular tissues were minced in a glass and homogenized by a teflon–
glass blender in cold physiological saline on ice. Then, the tissues were
diluted with a 9-fold volume of phosphate buffer (pH 7.4).
2.3. Evaluation of sperm parameters
The epididymal sperm concentration was determined with a
hemocytometer using a modified method described by Türk et al.
[12,29]. The right epididymis was finely minced by anatomical
scissors within 1 ml of isotonic saline in a Petri dish. It was completely
squashed by a tweezers for 2 min, and then allowed to incubate at
room temperature for 4 h to provide the migration of all spermatozoa
from epididymal tissue to fluid. After incubation, the epididymal
tissue-fluid mixture was filtered via strainer to separate the
supernatant from tissue particles. The supernatant fluid containing
all epididymal spermatozoa was drawn into the capillary tube up to
0.5 lines of the pipette designed for counting red blood cells. The
solution containing 0.595 M sodium bicarbonate, 1% formalin and
0.025% eosin was pulled into the bulb up to 101 lines of the pipette.
This gave a dilution rate of 1:200 in this solution. Approximately 10 µl
of the diluted sperm suspension was transferred to both counting
chamber of Improved Neubauer (Deep 1/10 mm, LABART, Darmstadt,
Germany) and allowed to stand for 5 min. The sperm cells in both
chambers were counted with the help of light microscope at 200×
magnification.
The percentage of sperm motility was evaluated using a light
microscope with heated stage as described by Sönmez et al. [36]. For
this process, a slide was placed on a light microscope with a heated
stage warmed up to 37 °C, and then several droplets of Tris buffer
solution [0.3 M Tris (hydroxymethyl) aminomethane, 0.027 M glu-
cose, 0.1 M citric acid] were dropped on the slide and a very small
droplet of fluid obtained from left cauda epididymis with a pipette
was added to the Tris buffer solution and mixed by a cover-slip. The
percentage of sperm motility was evaluated visually at 400×
magnification. Motility estimates were performed from 3 different
fields in each sample. The mean of the 3 successive estimations was
used as the final motility score. To determine the percentage of
morphologically abnormal spermatozoa, the slides stained with
eosin–nigrosin (1.67% eosin, 10% nigrosin and 0.1 M sodium citrate)
were prepared. The slides were then viewed under a light microscope
at 400× magnification. A total of 300 spermatozoa were examined on
each slide (3000 cells in each group), and the head, tail and total
abnormality rates of spermatozoa were expressed as percentage
[12,29].
2.4. Biochemical analyses
The testicular tissue lipid peroxidation levels were measured
according to the concentration of thiobarbituric acid reactive
substances (TBARs) [37]. The amount of produced malondialdehyde
(MDA) was used as an index of lipid peroxidation. Briefly, one volume
of the test sample and two volume of stock reagent (15%, w/v
trichloroacetic acid in 0.25 N HCl and 0.375%, w/v thiobarbituric acid
in 0.25 N HCl) were mixed in a centrifuge tube. The solution was
heated in boiling water for 15 min. After cooling, the precipitate was
removed by centrifugation at 1500g for 10 min, and then absorbance
of the supernatant was read at 532 nm against a blank containing all
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reagents except test sample on a spectrophotometer (Shimadzu 2R/
UV-visible, Tokyo, Japan). The MDA level was expressed as nmol/ml.
The reduced glutathione (GSH) level of testicular tissue was
measured at 412 nm using themethod of Sedlak and Lindsay [38]. The
samples were precipitated with 50% trichloroacetic acid, and then
centrifuged at 1000g for 5 min. The reactionmixture contained 0.5 ml
of supernatant, 2.0 ml of Tris–EDTA buffer (0.2 mol/l; pH 8.9) and
0.1 ml of 0.01 mol/l 5,5′-dithio-bis-2-nitrobenzoic acid. The solution
was kept at room temperature for 5 min, and then read at 412 nm on
the spectrophotometer. The level of GSH was expressed as nmol/ml.
The glutathione-peroxidase (GSH-Px) activity in testicular tissue
was determined according to the method of Lawrence and Burk [39].
The reaction mixture consisted of 50 mM potassium phosphate buffer
(pH 7.0), 1 mM EDTA, 1 mM sodium azide (NaN3), 0.2 mM reduced
nicotinamide adenine dinucleotide phosphate (NADPH), 1 IU/ml
oxidized glutathione (GSSG)-reductase, 1 mM GSH, and 0.25 mM
H2O2. Enzyme source (0.1 ml) was added to 0.8 ml of the above
mixture and incubated at 25 °C for 5 min before initiation of the
reaction with the addition of 0.1 ml of peroxide solution. The
absorbance at 340 nm was recorded for 5 min on a spectrophotom-
eter. The activity was calculated from the slope of the lines as
micromoles of NADPH oxidized per minute. The blank value (the
enzyme was replaced with distilled water) was subtracted from each
value. The protein concentration was also measured by the method of
Lowry et al. [40]. The GSH-Px activity was expressed as IU/g protein.
The testicular tissue catalase (CAT) activity was determined by
measuring the decomposition of hydrogen peroxide (H2O2) at
240 nm, according to the method of Aebi [41], and was expressed as
kU/g protein, where k is the first-order rate constant.
2.5. Histopathological examination
The testicular tissues were fixed in 10% formalin, embedded in
paraffin, sectioned at 5 μm and were stained with haematoxylin and
eosin [42]. Light microscopy was used to measure diameters of semi-
niferous tubules (DST) andof germinal cell layer thicknesses (GCLT) and
to evaluate the damages in testicular tissue. The degree of damages was
graded as follows: mild (+), moderate (++) and severe (+++).
2.6. Statistical analysis
All values were presented as mean±S.E.M. Differences were
considered to be significant at Pb0.05. One-way analysis of variance
(ANOVA) and post hoc Tukey-HSD test were used to determine
differences between groups. The SPSS/PC program (Version 10.0;
SPSS, Chicago, IL) was used for the statistical analysis.
3. Results
3.1. Effects of CsA and EA treatments on reproductive organ weights and
epididymal sperm characteristics
Table 1 shows the changes in the reproductive organ weights and
epididymal sperm characteristics in response to various treatments
for a 21 day treatment period. No statistically significant differences
were observed between control and ellagic acid groups in terms of
reproductive organ weights. However, alone CsA administration
caused a statistically significant reduction (Pb0.01) in weights of
testes and ventral prostate and insignificant reduction (PN0.05) in
epididymal and seminal vesicle weights compared to the control
group. A marked (Pb0.01) increase in cyclosporine+ellagic acid
group was observed in testis weight compared to alone cyclosporine
group. Increments observed in epididymal, seminal vesicle and
ventral prostate weights in cylosporine+ellagic acid group were
statistically insignificant in comparison to the alone cyclosporine
group.
Only EA administration for 21 days did not markedly alter all the
studied sperm characteristics when compared to the control group.
Alone CsA treatment significantly decreased sperm concentration and
sperm motility and, it increased the percentage of head (Pb0.05), tail
and total (Pb0.01) abnormality of sperm in comparison to the control
group. The administration of EA to CsA-treated rats significantly
protected the CsA-induced negative changes in sperm motility
(Pb0.05) and total abnormality (Pb0.01) versus alone cyclosporine
group. Although the values of sperm concentration were numerically
higher and, head and tail abnormality percentages were also
numerically lower in cyclosporine+ellagic acid group than values
in alone cyclosporine group, the differences were not statistically
significant.
3.2. Effects of CsA and EA treatments on biochemical parameters
Markers of testicular tissue lipid peroxidation and antioxidant
enzyme activities of all the groups are given in Table 2. Alone EA
treatment remained ineffective on MDA and GSH levels, GSH-Px and
CAT activities in comparison to the control group. While CsA
administration resulted in a significant (Pb0.01) increase in MDA
level when compared to the control group, the CsA+EA treatment
provided a marked reduction (Pb0.01) in the increased MDA levels
versus alone cyclosporine group.
Alone CsA treatment decreased the GSH levels, GSH-Px and CAT
(Pb0.01) activities when compared to the control group. However,
Table 1












Testes (g) 1.388±0.03 1.372±0.02 1.004±0.07a 1.256±0.03b
Epididymides (g) 0.361±0.027 0.407±0.004 0.314±0.017c 0.376±0.010
Seminal vesicles (g) 0.868±0.03 0.980±0.04 0.506±0.10c 0.852±0.13




317.2±17.0 350.4±24.1 203.3±25.2d 275.8±41.8




Head 2.93±1.02 1.93±0.49 6.48±0.68d 3.60±0.53
Tail 3.53±0.20 2.80±0.64 9.93±1.57a 5.80±0.36
Total 6.46±1.13 4.73±0.52 16.41±1.91a 9.40±0.62b
a Different from control group (Pb0.01).
b Different from cyclosporine group (Pb0.01).
c Different from ellagic acid group (Pb0.01).
d Different from control group (Pb0.05).
e Different from cyclosporine group (Pb0.05).
Table 2
Mean±SEM values of testicular tissue malondialdehyde (MDA) and glutathione (GSH)











MDA (nmol/ml) 14.59±0.24 14.48±0.68 21.63±0.34a 16.42±0.72b
GSH (nmol/ml) 3.72±0.20 4.16±0.11 2.61±0.08a 3.27±0.24b,c
GSH-Px
(IU/g protein)
47.70±1.96 54.09±2.44 29.48±1.22a 43.30±0.35b,c
CAT
(kU/g protein)
60.24±2.43 63.86±3.02 44.05±1.54a 54.59±2.19b
a Different from control group (Pb0.01).
b Different from cyclosporine group (Pb0.01).
c Different from ellagic acid group (Pb0.01).
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administration of EA to CsA-treated rats prevented the CsA-induced
decreases in these endogenous antioxidants.
3.3. Effects of CsA and EA treatments on testicular histopathology
Measured DST and GCLT values and scored histopathological
changes are presented in Table 3. While alone EA application did not
significantly alter theDST andGCLT compared to the control group, only
CsA administration caused a significant (Pb0.001) decrease in these
parameters. CsA plus EA treatment provided a marked (Pb0.001)
amelioration in these measurements. When the structure of testes was
histopathologically examined; it was observed that histological appear-
ances of testicular tissues of control (Fig. 1C) and ellagic acid (Fig. 1D)
groups were normal. The histopathological changes were observed in
alone cyclosporine and cyclosporine+ellagic acid groups. Atrophy in
DST, necrosis in germinal cells, degeneration, interstitial oedema,
capillary congestion and spermatogenic arrest were marked damages
in testicular tissue in alone cyclosporine group. Spilled immature
spermatogonia and spermatocyteswere encountered in lumensof some
seminiferous tubules of alone CsA-treated group (Fig. 1A). It was
determined that there are marked decreases in immaturation, necrotic
and degenerative changes in germinal cells of rats given CsA alongwith
EA compared to the cyclosporine group (Fig. 1B).
4. Discussion
The use of CsA has improved quality of life and survival of
transplant patients by largely contributing to the decrease in
Table 3
Diameters of seminiferous tubules (DST), germinal cell layer thicknesses (GCLT) and the degree of damages in testicular tissue [mild (+), moderate (++), severe (+++)].
Groups
Parameters Control (n=10) Ellagic acid (n=10) Cyclosporine (n=10) Cyclosporine+ellagic acid (n=10)
Immature spermatogonia and spermatocytes ND ND 1.14±0.26a 0.29±0.18b
Interstitial oedema ND ND 0.57±0.20a NDb
Reduction in germinal cell layer thickness ND ND 1.29±0.18a 0.43±0.20a,b
Atrophy in seminiferous tubules ND ND 1.14±0.26a 0.43±0.20a
Capillary congestion ND ND 0.57±0.30 0.29±0.20
Necrosis in seminiferous tubules ND ND 0.71±0.29a 0.29±0.18
Degeneration in seminiferous tubules ND ND 1.57±0.30a 1.00±0.00a,b
Spermatogenic arrest ND ND 1.29±0.18a 0.71±0.18a,b
DST (µm) 223.68±2.08 221.04±2.31 205.44±3.04a 213.20±2.73a,b
GCLT (µm) 55.12±0.84 55.04±0.59 48.56±0.95a 52.56±0.64a,b
ND: not detected.
a Different from both control and ellagic acid groups (Pb0.01).
b Different from cyclosporine group (Pb0.01).
Fig. 1. A. Severe atrophy in DST, necrosis in germinal cells, degeneration, spermatogenic arrest, interstitial oedema and congestion in alone CsA-treated group. B. Mild disorganisation
in germinal cells, degeneration and interstitial oedema in CsA+EA group. C. Normal histological view of seminiferous tubules in control group. D. Normal histological view of
seminiferous tubules in EA group (H&E×100).
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morbidity, rejection reactions and hospitalization days [6]. However,
clinical use of CsA is limited due to its unwanted side-effects in
different organs such as kidney, heart, liver in transplanted patients
[43–45]. It has been reported that the CsA administration causes a
dose-dependent decline (20 mg/kg or higher) in the reproductive
organ weights of non-transplanted male rats [13–15]. However the
findings of studies of our earlier [12] and Monteiro et al. [46] have
demonstrated that CsA has no significant effect on testicular weight.
Alone CsA administration caused a significant decrease in testicular
weight in the present study. The differences among present, our
earlier [12] and Monteiro et al. [46] studies can be attributed to the
sensitivity of rats used in different works. The reduction in testicular
weight may be explained by CsA-induced direct or indirect (via ROS)
atrophy in DST and decreased GCLT. CsA-induced increased ROS levels
or its direct effects lead to decrease in testosterone production [47]
and volumetric proportion of Leydig sells [46]. The reduction in
prostatic weight observed in the study may be explained that the
secretion of this organ likely decreased because testosterone
production was diminished by CsA.
Spermatozoa are particularly susceptible to the damage induced
by excessive ROS, because their plasma membranes contain large
quantities of polyunsaturated fatty acids and their cytoplasm contains
low concentrations of scavenging enzymes [18,19]. ROS can attack to
the unsaturated bonds of the membrane lipids in an autocatalytic
process, with the genesis of peroxides, alcohol and lipidic aldehydes
as by-product of the reaction. Thus, the increase of free radicals in cells
can induce the lipid peroxidation by oxidative breakdown of
polyunsaturated fatty acids in membranes of cells. Obviously,
peroxidation of sperm lipids destroys the structure of lipid matrix in
the membranes of spermatozoa, and it is associated with rapid loss of
intracellular ATP leading to axonemal damage, decreased sperm
viability and increased mid-piece morphological defects, and even it
completely inhibits spermatogenesis in extreme cases [12,29]. Xu et
al. [48] have reported that different dosages of CsA affect sperm
morphology of human after renal transplantation. Misro et al. [16]
reported that in vitro addition of 1 mg/kg CsA reduces human sperm
motility. In our earlier study [12], we showed that 15 mg/kg CsA
caused reduced epididymal sperm concentration, sperm motility and
increased morphologically abnormal sperm in non-transplanted
healthy rats. Daily administration of CsA significantly reduced
epididymal sperm concentration, sperm motility and increased
abnormal sperm rate compared to the control group in this study.
Our findings are in agreement with above reports. The negative
changes observed in sperm quality in the present study may be
attributed to the peroxidation of polyunsaturated fatty acids in
plasma membranes of spermatozoa, damaged flagellum which
important machinery for the sperm motility, directly impairing of
spermatogenic cell development, impaired maturation or spermia-
tion, and altered membrane porosity caused by CsA administration.
CsA leads to seminiferous epithelium degeneration, resulting in
Sertoli cell vacuolization, abnormal round and elongated spermatids,
large accumulation of residual cytoplasm at the epithelium border
next to the lumen of tubules, reduced haploid cell population,
pachytene spermatocytes, decreases in DST and GCLT, necrosis,
interstitial oedema, desquamative germinal cells and the deceleration
of spermatogenesis [10,12,46]. In this study, similar lesions and
findings were observed in alone CsA-treated rats. The damages
observed in the histological structure of testis in this work may be
elucidated with the direct or indirect effect of CsA which latter
induces lipid peroxidation that is a chemical mechanism capable of
disrupting the structure and function of testis.
The use of oxygen during normal metabolism produces ROS, some
of which are highly toxic and deleterious to cells and tissues. Themost
abundant ROS formed in the course of cellular metabolism is O2−

[49].
Dismutation of the O2−

or directly from the action of oxidase enzymes
gives rise to H2O2. This molecule is not a free radical itself but, in the
presence of transition metals (Cu+2, Fe+2) via the Fenton reaction, it
is rapidly converted to the UOH. The UOH is widely accepted as being
the most damaging ROS produced by cells [50]. CsA-induced-free
radicals have a great potential to react rapidly with lipids which in
turn leads to lipid peroxidation. Alone CsA treatment caused
significant increase in MDA level of testicular tissue in the present
study.
When ROS begin to accumulate, testes exhibit a defensive
mechanism using various antioxidant enzymes. The first enzymatic
reaction in the reduction pathway of oxygen occurs during the
dismutation of two molecules of O2−

when they are converted to H2O2
and diatomic oxygen. The enzyme at this step is superoxide dismutase
(SOD). Twoenzymesparticipate in the removalofH2O2 fromthecellular
environment, peroxidases and CAT. The most abundant peroxidase is
the GSH-Px. This enzyme uses reduced GSH as a substrate to transfer
electrons to H2O2 (and other peroxides) thereby converting it into two
molecules of water [51]. In the present study, it was found that only CsA
administration decreased the GSH levels, GSH-Px and CAT activities
when compared to the control group. Decreases in enzymatic and non-
enzymatic antioxidants observed in this work may be attributed to
excessive utilisation of these antioxidants in order to scavenge the free
radicals lead to lipid peroxidation.




OH in both enzymatic and non-
enzymatic systems by its metal-chelating property, thus providing
protection against lipid peroxidation [9]. In our earlier studies we
found that EA protected cisplatin-induced testicular and spermato-
zoal toxicity by decreasing lipid peroxidation in testes [29]. Addition-
ally, it has been reported that EA decreases MDA level and increases
GSH level [35], GSH-Px and CAT activities [9] in various organs of rats
treated with CsA. In the present study, administration of EA provided
total or partial improvements in sperm parameters, testicular
histology, lipid peroxidation and antioxidant enzyme activities in
CsA-treated rats. This status may be explained with partial attenua-
tion of CsA-induced degeneration, reduction in GCLT, and possibly
enhancement of sperm concentration in the epididymis, and
increment in fluids of accessory glands due to the decreased lipid
peroxidation and increased antioxidant enzyme activities caused by
EA administration. The declining of lipid peroxidation in testicular
tissue apparently indicates that EA potently scavenged the free
radicals, and suppressed oxidative DNA damage.
In conclusion, this study apparently suggests that EA has a
protective effect against testicular and spermatozoal toxicity induced
by CsA. This protective effect of EA seems to be closely involved with
the suppressing of oxidative stress. Therefore, EA may be used
combined with CsA after transplantation and in autoimmune diseases
to improve CsA-induced injuries in sperm quality and oxidative stress
parameters.
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